Young Alethia — SEC Form 4 filings
SEC reporting owner CIK 1918147. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 8,524 shares, $57,762 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 3,289 shares @ $6.80 ($22,365) in BICYCLE THERAPEUTICS PLC, filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | 4 | — | 7 legs · 8,524 sh · $57,762 | 2 |
| PTC THERAPEUTICS, INC. (PTCT) | Director | 3 | — | — | 6 |
| Pacira BioSciences, Inc. (PCRX) | Director | 3 | — | — | 6 |
Form 4 filings — Young Alethia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/award (A): 50,000 @ $0 · Sale (S): 3,289 @ $6.80 · Sale (S): 2,456 @ $6.45 · Sale (S): 1,878 @ $6.54 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 217 @ $8.40 · Sale (S): 265 @ $8.61 | EDGAR |
| 2025-07-07 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 204 @ $7.09 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-04-04 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 215 @ $8.02 | EDGAR |
| 2025-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1918147 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →